CVR 25942167Private limited company (ApS)Uoplyst (999999)København ØFounded 12 Mar 2001
CVR registers no owner holding 5% or more.
CVR holds no employment figures for this company.
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about NW BIOTECH INVEST ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexResult
-6.3M
DKK, annual report 2013
Equity
-5M
DKK, annual report 2013
CVR registers no owner holding 5% or more.
Nicolai Winding Andersenuntil 9 Jun 2015
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2013, DKK: Operating profit -6.3M, Result for the year -6.3M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2013, DKK: Total assets 40.6K, Equity -5M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2009 | 2010 | 2011 | 2012 | 2013 |
|---|---|---|---|---|---|
| Operating profit | Not reported | Not reported | Not reported | +4,455 | -6,262 |
| Result for the year | Not reported | Not reported | Not reported | +4,120 | -6,271 |
| Equity | Not reported | Not reported | Not reported | 1,223 | -5,048 |
| Total assets | Not reported | Not reported | Not reported | 6,304 | 41 |
| Credit metrics (Dandex calculations) | |||||
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||||
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions.
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
What Pro holds for NW BIOTECH INVEST ApS:
Have Pro? Sign in.
Amounts in DKK.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| FoundingNot read from the announcement | None | None | None | 125,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
Source: CVR, read 19 Nov 2026.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 19 Nov 2026.
12 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Skifteretsbehandlingen sluttet, virksomheden er opløst
Likvidatorer:
Fratrådte:
Marianne Philip, den 10.08.2018.
Likvidatorer:
Tiltrådte:
Sø- og Handelsrettens Skifteretsafdeling har udnævnt følgende likvidatorer: Marianne Philip, 2100 København Ø, den 11.09.2015.
Virksomheden tegnes af en likvidator.
Virksomhedens kreditorer opfordres til at anmelde deres krav til likvidator. Krav skal anmeldes senest tre måneder fra dags dato.
CVR-nummer:
25942167.
NAVN:
NW BIOTECH INVEST ApS.
Adresse: Sankt Jakobs Gade 9, 3. th., 2100 København Ø.
Kommune: København.
Anmodning om opløsning, jf. selskabslovens § 225 sendt til Sø- og Handelsrettens Skifteretsafdeling den 09.07.2015
CVR-nummer:
25942167.
NAVN:
NW BIOTECH INVEST ApS.
Adresse: Sankt Jakobs Gade 9, 3. th., 2100 København Ø.
Kommune: København.
Direktion:
Fratrådte:
Nicolai Winding Andersen, den 09.06.2015.
Revision:
Fratrådte:
RSM PLUS P/S STATSAUTORISEREDE REVISORER, den 09.06.2015.
Revision:
Udtrådt af revisionen:
KPMG STATSAUTORISERET REVISIONSPARTNERSELSKAB, den 01.05.2010.
Indtrådt i revisionen:
CVR-NR. 12523246 GRANT THORNTON, STATSAUTORISERET REVISIONSAKTIESELSKAB, Stockholmsgade 45, 2100 København Ø, den 01.05.2010.
Revision:
Udtrådt af revisionen:
KPMG C. Jespersen Statsautoriseret Revisionsinteressentskab, den 18.12.2008.
Indtrådt i revisionen:
KPMG STATSAUTORISERET REVISIONSPARTNERSELSKAB, Værkmestergade 25, 8000 Århus C, den 18.12.2008.
Ny adresse:
Skt. Jakobs Gade 9, 3. th., 2100 København Ø.
Vedtægter ændret:
10.10.2001.
Nyt navn:
NW BIOTECH INVEST ApS.
Bestyrelse:
Udtrådt af bestyrelsen:
Jan-Erik Gunnar Svensson, den 10.10.2001, Troels Elkiær Andersen, den 10.10.2001, Klaus Søgaard, den 10.10.2001.
Direktion:
Udtrådt af direktionen:
Klaus Søgaard, den 10.10.2001.
Indtrådt i direktionen:
Nicolai Winding Andersen, den 10.10.2001.
Selskabet tegnes af en direktør.
Revision:
Udtrådt af revisionen:
PricewaterhouseCoopers, den 10.10.2001.
Indtrådt i revisionen:
KPMG C. Jespersen, Statsautoriserede revisorer, 2000 Frederiksberg, den 10.10.2001.
Stiftelsesdato:
12.03.2001.
Seneste vedtægtsdato:
12.03.2001.
Kapital:
kr. 125.000,00.
Indbetalingsmåde:
kontant kr. 125.000,00 til kurs 100,00.
Stifter:
CVR-NR. 13738580 GFK HOLDING ApS, c/o adv. Klaus Søgaard, H.C. Andersens Boulevard 12, 1553 København V, den 12.03.2001.
Bestyrelse:
Advokat Jan-Erik Gunnar Svensson (formand), den 12.03.2001, Advokat Troels Elkiær Andersen, den 12.03.2001, Advokat Klaus Søgaard, den 12.03.2001.
Direktion:
Advokat Klaus Søgaard, den 12.03.2001.
Selskabet tegnes af to medlemmer af bestyrelsen i forening eller af et medlem af bestyrelsen i forening med en direktør.
Revision:
PricewaterhouseCoopers, 2900 Hellerup, den 12.03.2001.
Første regnskabsår:
12.03.2001 - 31.12.2001.
Regnskabsår:
01.01 - 31.12.
P-number 1008331185Sankt Jakobs Gade 9, 2100 København Ø